News Release: April 29, 2025
Erucamide (cis-13-Docosenamide) Price Trend and Production News
The global Erucamide (cis-13-Docosenamide) market has witnessed a series of price and production shifts over the past few years, culminating in major developments in 2025. For a detailed outlook on Erucamide (cis-13-Docosenamide) price trend and production News, please visit Datavagyanik’s Market Report.
Erucamide (cis-13-Docosenamide) Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
From 2019 through 2024, the Erucamide (cis-13-Docosenamide) price trend has been dynamic, reflecting global supply chain adjustments, raw material volatility, and evolving demand patterns in plastics, paper, textile, and coating industries. In 2019, the average global Erucamide (cis-13-Docosenamide) price hovered around $3,800/MT. This relatively stable phase was characterized by balanced supply-demand dynamics.
However, entering 2020, the COVID-19 pandemic disrupted production facilities, causing average prices to increase to around $4,200/MT due to supply shortages. Demand from packaging and hygiene products partially offset declines from other industrial sectors.
In 2021, as economies reopened, Erucamide (cis-13-Docosenamide) production expanded, stabilizing prices back to approximately $3,950/MT. Notably, strong demand from the flexible packaging sector sustained the sales volume. The Erucamide (cis-13-Docosenamide) price trend during this year indicated resilience, despite logistical bottlenecks.
The year 2022 was marked by substantial energy cost hikes and disruptions in oilseed production, notably in regions producing rapeseed and mustard seeds — critical feedstocks for Erucamide (cis-13-Docosenamide). Consequently, prices surged again to $4,500/MT. Producers in Asia and Europe faced margin pressures, pushing procurement costs higher.
2023 saw gradual easing. Improved crop yields and more diversified sourcing led the Erucamide (cis-13-Docosenamide) price down to about $4,050/MT by year-end. Nevertheless, fluctuating freight rates and port congestions, especially in major export hubs like China and India, kept the price volatility alive.
In early 2024, rising interest rates and tightening liquidity somewhat restrained Erucamide (cis-13-Docosenamide) sales volume growth. However, consistent demand from specialty applications such as lubricants and food packaging additives maintained moderate upward price pressures, bringing the global average to $4,200/MT by December 2024.
The key factors impacting the Erucamide (cis-13-Docosenamide) price trend over these five years included:
- Disruptions in agricultural feedstock availability.
- Transportation and container shortages.
- Energy cost fluctuations, especially natural gas prices.
- Increasing environmental regulations prompting shifts to bio-based additives.
Erucamide (cis-13-Docosenamide) Price Trend Quarterly Update in $/MT: (2025 Estimates)
As of 2025, Erucamide (cis-13-Docosenamide) price news points towards a cautiously optimistic scenario. Production has stabilized across major hubs, and new investments in high-purity processing technologies are strengthening supply chains.
Estimated quarterly average prices for 2025 are:
- Q1 2025: $4,250/MT
(Recovery of seasonal demand from coatings and flexible packaging sector in North America and Europe.)
- Q2 2025: $4,300/MT
(Mid-year stocking activities by converters and surge in demand from Asia-Pacific region.)
- Q3 2025: $4,270/MT
(Cooling demand post-summer with minor inventory corrections.)
- Q4 2025: $4,350/MT
(Festive season packaging demand, increased requirement for anti-block agents in flexible films.)
The Erucamide (cis-13-Docosenamide) price trend in 2025 is largely expected to follow a moderately upward trajectory, anchored by a healthy balance between Erucamide (cis-13-Docosenamide) production expansions and sustained end-use industry growth.
Moreover, strategic partnerships between Erucamide (cis-13-Docosenamide) manufacturers and packaging companies are further enhancing pricing stability for the coming quarters.
Global Erucamide (cis-13-Docosenamide) Import-Export Business Overview
The global Erucamide (cis-13-Docosenamide) trade has become a vital component in ensuring stable supply chains across regions. Key exporting countries include China, India, Malaysia, and Germany. Major importers remain the United States, Japan, South Korea, Brazil, and select European nations.
Export Landscape:
China has emerged as the leading Erucamide (cis-13-Docosenamide) exporter, commanding nearly 35% of global exports by volume in 2024. Lower production costs, extensive raw material access, and advanced production capabilities have reinforced China’s dominance.
India follows closely, contributing approximately 22% to global exports. Indian manufacturers are focusing increasingly on high-purity grades that are gaining traction across North American and European markets. Additionally, government support through export incentives is bolstering India’s Erucamide (cis-13-Docosenamide) sales volume abroad.
Germany remains Europe’s major Erucamide (cis-13-Docosenamide) supplier, although its exports primarily cater to neighboring countries like France, Italy, and the Netherlands. Environmental compliance costs are relatively higher here, translating into premium-priced material.
Import Trends:
The United States continues to be the largest single-country importer, accounting for nearly 18% of global Erucamide (cis-13-Docosenamide) imports. Its diversified application base across packaging, paper coatings, and lubricants sustains high demand.
Japan and South Korea show steady import growth as domestic production capacities remain limited. The rapid advancement of electronics and flexible displays in these countries is further boosting the Erucamide (cis-13-Docosenamide) import requirement, especially for high-purity formulations.
Brazil and Mexico are emerging as important destinations within Latin America, where expanding flexible packaging sectors are fueling Erucamide (cis-13-Docosenamide) consumption.
Trade Volumes and Business Highlights (2025):
- Global Erucamide (cis-13-Docosenamide) trade volume is forecasted to grow by 4.8% YoY in 2025.
- China’s exports to Southeast Asia and Africa are expected to increase by around 6% as new bilateral trade agreements come into effect.
- The U.S. is projected to increase its import volume by approximately 3% in 2025 due to rising industrial production rates.
- Europe’s internal trade is showing resilience with Germany and France strengthening bilateral Erucamide (cis-13-Docosenamide) trade ties.
- Emerging markets such as Vietnam, Indonesia, and Nigeria are being targeted by exporters due to growing packaging industries.
Trade Challenges:
Despite the optimistic outlook, challenges remain. Stringent environmental regulations in Europe and the U.S. are pressuring producers and exporters to adopt more sustainable and compliant production practices.
Additionally, shipping container shortages, although easing, still impact smaller exporters in Southeast Asia and Latin America. Currency volatility, especially concerning the Chinese Yuan and Indian Rupee against the USD, could also influence pricing dynamics in global transactions.
Forward-Looking Strategies:
Manufacturers and exporters are adopting several strategic moves to enhance resilience:
- Setting up regional warehouses closer to key consumption hubs to reduce lead times.
- Investing in vertical integration from feedstock processing to finished Erucamide (cis-13-Docosenamide) production.
- Engaging in joint ventures with logistic companies to secure freight capacities.
Key Developments in 2025:
- A new 10,000 MT per annum Erucamide (cis-13-Docosenamide) production facility is being commissioned in Malaysia to target the Asia-Pacific demand surge.
- Indian manufacturers are launching “Green Erucamide” grades with reduced carbon footprint aimed at the European Union.
- U.S.-based converters are entering into long-term contracts with Asian suppliers to hedge against future supply shocks.
As global demand for bio-based anti-blocking agents rises, Erucamide (cis-13-Docosenamide) is poised to maintain its pivotal role across industries, supported by strategic global trade movements and production expansions.
For a deeper analysis of the Erucamide (cis-13-Docosenamide) price trend, production, and market dynamics, request a sample report here.
Erucamide (cis-13-Docosenamide) Production Trends by Geography
The global production landscape for Erucamide (cis-13-Docosenamide) has shifted considerably in recent years, with manufacturing bases diversifying to meet rising demand across various industries. The geographical distribution of Erucamide (cis-13-Docosenamide) production now reflects strategic expansions, regulatory considerations, feedstock availability, and logistical efficiencies.
Asia-Pacific
Asia-Pacific holds the largest share of global Erucamide (cis-13-Docosenamide) production, accounting for over 55% of the global output. China and India are the two dominant players in this region. China has built large-scale Erucamide (cis-13-Docosenamide) facilities that benefit from lower raw material and labor costs, leading to competitive pricing on a global scale.
India’s production is growing steadily due to its robust agricultural base for oilseed crops like mustard and rapeseed, which are primary feedstocks for Erucamide (cis-13-Docosenamide). Indian manufacturers focus heavily on export-oriented production, catering especially to European and North American demand for specialty-grade Erucamide (cis-13-Docosenamide).
Other Asia-Pacific countries such as Malaysia and Thailand are emerging contributors, with investments focused on environmentally sustainable and high-purity Erucamide (cis-13-Docosenamide) manufacturing.
North America
North America, particularly the United States, has a well-established Erucamide (cis-13-Docosenamide) production network, although much smaller compared to Asia. Domestic production primarily serves internal demand across the flexible packaging, coatings, and personal care sectors.
Recent investments are aimed at boosting localized production capacities to minimize reliance on imports from Asia. Innovations in bio-based and low-carbon Erucamide (cis-13-Docosenamide) variants are helping North American producers carve out niche market segments, particularly as environmental regulations become stricter.
Canada is also making minor but significant advancements, focusing on premium grades intended for food-grade and pharmaceutical applications.
Europe
Europe remains a critical region for Erucamide (cis-13-Docosenamide) production, albeit with a strong tilt toward specialty, high-purity, and sustainable products. Germany, Belgium, and the Netherlands are the key production hubs within Europe.
European manufacturers are particularly focused on compliance with strict regulatory frameworks such as REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals), driving investments toward greener and purer Erucamide (cis-13-Docosenamide) solutions.
However, rising energy costs and environmental taxes pose challenges, compelling several producers to establish satellite production units in Eastern Europe to lower operational expenses while remaining close to major consumer markets.
Latin America
Latin America is an emerging market for Erucamide (cis-13-Docosenamide) production, with Brazil and Argentina at the forefront. Both countries benefit from extensive cultivation of oilseed crops, making feedstock sourcing highly cost-effective.
Brazil has witnessed the establishment of mid-sized Erucamide (cis-13-Docosenamide) production facilities aimed at catering to regional packaging and polymer industries. The focus remains on meeting local demand while slowly scaling toward export opportunities, particularly within the MERCOSUR trade bloc.
Middle East and Africa
Production capacities in the Middle East and Africa remain limited but are expected to grow steadily. South Africa has seen modest investments into Erucamide (cis-13-Docosenamide) production plants, largely supported by demand from the regional plastics and coatings sectors.
The Middle East, especially countries like Saudi Arabia and the UAE, is exploring Erucamide (cis-13-Docosenamide) production through integrated petrochemical projects. However, progress remains slow due to a stronger focus on hydrocarbons and core petrochemical streams.
Production Trend Outlook for 2025 and Beyond
Global Erucamide (cis-13-Docosenamide) production is anticipated to grow at a CAGR of approximately 4.5% between 2025 and 2030. Asia-Pacific will continue to dominate, but production in North America and Latin America will expand at a faster rate relative to the base year, driven by localized demand and trade uncertainty mitigation strategies.
Manufacturers are increasingly investing in technology upgradation, feedstock diversification, and sustainable production models to future-proof their market positions amid tightening global environmental norms.
Erucamide (cis-13-Docosenamide) Market Segmentation
The Erucamide (cis-13-Docosenamide) market is segmented across various parameters based on end-use industry, grade, and geographic usage. Understanding the market segmentation provides a clearer picture of how demand is structured and where growth opportunities are emerging.
Market Segmentation Points:
- By End-use Industry
- Packaging
- Textile
- Paper and Pulp
- Coatings
- Personal Care
- Lubricants
- Pharmaceuticals
- By Grade
- Industrial Grade
- Food Grade
- Pharmaceutical Grade
- By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
End-Use Industry Analysis
Packaging dominates the Erucamide (cis-13-Docosenamide) market, accounting for over 45% of total demand. As a slip agent, Erucamide (cis-13-Docosenamide) reduces friction in polyethylene and polypropylene films, enhancing packaging efficiency and durability. The rise of flexible packaging, particularly in food, beverages, and consumer goods, drives this segment’s growth.
Textile applications utilize Erucamide (cis-13-Docosenamide) for anti-blocking properties in fibers and films. The demand from technical textiles used in automotive and construction sectors further supports the growth of this segment.
Paper and Pulp industry demand stems from Erucamide (cis-13-Docosenamide)’s role in providing lubricity and anti-block properties to coated papers. The increasing push for recyclable and biodegradable coatings aligns with Erucamide (cis-13-Docosenamide)’s bio-based profile, expanding its applications here.
Coatings sector benefits from Erucamide (cis-13-Docosenamide)’s ability to enhance surface slip and anti-blocking in paints, varnishes, and inks. Rising global infrastructure development and automotive refinishing projects support steady growth in this application.
Personal Care products such as creams and lotions integrate Erucamide (cis-13-Docosenamide) for its emollient properties. Growth in natural and organic cosmetics trends fuels additional demand.
Lubricants industry increasingly uses Erucamide (cis-13-Docosenamide) as an additive to enhance thermal stability and frictional properties. The shift toward high-performance lubricants, especially in industrial and automotive sectors, opens up new opportunities.
Pharmaceuticals sector leverages food- and pharma-grade Erucamide (cis-13-Docosenamide) in tablet coatings and drug delivery formulations, where anti-sticking properties are critical.
Grade-Based Segmentation
Industrial Grade Erucamide (cis-13-Docosenamide) accounts for the largest volume, driven by widespread use in packaging, textiles, and coatings. These products prioritize cost-efficiency and functional performance over extreme purity.
Food Grade Erucamide (cis-13-Docosenamide) finds applications primarily in food packaging films where compliance with food safety standards is mandatory. This segment is growing faster than industrial grade due to tightening food safety regulations worldwide.
Pharmaceutical Grade Erucamide (cis-13-Docosenamide) holds a niche but highly profitable segment. Demand growth is robust as innovations in pharmaceutical coatings and novel drug formulations expand the functional needs for anti-block agents.
Geographic Segmentation
North America is a mature but innovating market, focusing increasingly on sustainable and high-performance formulations. Stringent regulations and advanced R&D capabilities keep demand strong in specialized applications.
Europe is leading in regulatory-driven demand for sustainable Erucamide (cis-13-Docosenamide) variants. Growth is moderate but steady, particularly in Western Europe.
Asia-Pacific is the largest and fastest-growing market segment, fueled by massive consumption in packaging, automotive, and consumer goods industries. China, India, and Southeast Asian countries are at the core of this momentum.
Latin America is witnessing accelerated growth in flexible packaging and industrial lubricants sectors, boosting Erucamide (cis-13-Docosenamide) consumption.
Middle East and Africa markets are still emerging but present promising opportunities due to infrastructure development and growing consumer goods industries.
Future Outlook
Market segmentation trends indicate that food and pharmaceutical grade Erucamide (cis-13-Docosenamide) segments will grow at faster rates due to increasing regulatory scrutiny. Packaging and coatings will continue to dominate the industrial-grade demand, with Asia-Pacific remaining the epicenter of consumption and production.